PTC Therapeutics First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
PTC Therapeutics, Inc. (PTCT)
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ptcbio.com
Company Research
Source: Yahoo! Finance
Net loss: US$91.6m (loss narrowed by 34% from 1Q 2023). US$1.20 loss per share (improved from US$1.89 loss in 1Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period PTC Therapeutics Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 22%. Earnings per share (EPS) also surpassed analyst estimates by 5.4%. Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 18% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are up 13% from a week ago. Risk Analysis Don't forget that there may still be risks. For instance, we've identified 3 warning signs for PTC Therapeutics (1 shouldn't be ignored) you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in
Show less
Read more
Impact Snapshot
Event Time:
PTCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTCT alerts
High impacting PTC Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
PTCT
News
- PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts [Seeking Alpha]Seeking Alpha
- PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™ [Yahoo! Finance]Yahoo! Finance
- PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™PR Newswire
- PTC Therapeutics to Participate at Upcoming Investor ConferencesPR Newswire
- PTC Therapeutics, Inc. (NASDAQ: PTCT) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $30.00 price target on the stock, up previously from $28.00.MarketBeat
PTCT
Earnings
- 4/25/24 - Beat
PTCT
Sec Filings
- 5/10/24 - Form 4
- 5/8/24 - Form 4
- 5/7/24 - Form 144
- PTCT's page on the SEC website